ÂÜÀòÂÒÂ×

The Research and Development Team at Pliant Therapeutics is dedicated to advancing the company's drug development programs targeting fibrotic diseases. This team engages in the discovery, design, and optimization of novel therapies with a focus on fibrotic tissue-specific inhibition of integrins and the TGF-β pathway. Members collaborate closely to conduct experimental research, develop clinical candidates, and transition promising compounds from preclinical studies to clinical trials.